In Vitro Ocular Drug Model for Dynamic Diffusion Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing ocular models fail to adequately simulate the dynamic diffusion and convection phenomena in the eye after intravitreal drug delivery, leading to challenges in evaluating drug behavior and bioavailability due to the complex interactions between vitreous humor components and applied drugs.
Innovation Solution
A method and apparatus using a sample cell with a semi-permeable membrane and a continuous buffer fluid flow to simulate the physiological environment of the eye, allowing for the analysis of substance behavior, including the use of a buffer fluid resembling vitreous humor and a laminar flow to mimic dynamic conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a drug is injected directly into the vitreous humor, then bioavailability is improved, but the drug is exposed to rapid dilution, pH and temperature changes that can destabilize the API and lead to aggregation
Solution Approach 1:
The patent performs stability testing under simulated intravitreal injection conditions before actual administration. By pre-exposing the drug formulation to the harsh vitreous humor environment (rapid dilution, pH changes, temperature variations) in a controlled in vitro setting, the formulation's stability is evaluated and optimized in advance, allowing predictions about API stability and aggregation risk before clinical use
Solution Approach 2:
The patent creates an in vitro model that copies the complex physiological conditions of the vitreous humor environment. This includes simulating the protein matrix, pH conditions, temperature, and dilution effects to reproduce the actual intravitreal environment. By studying the drug behavior in this copied environment, researchers can assess stability and bioavailability without direct animal or human testing
2Device complexity
If existing ocular models are used to evaluate drug behavior, then device complexity is reduced, but the models fail to adequately simulate dynamic diffusion and convection phenomena
Solution Approach 1:
The patent introduces dynamic elements into the in vitro model by simulating convection currents and diffusion processes that occur naturally in the vitreous humor after intravitreal injection. The model incorporates movement and flow patterns that replicate the dynamic physiological environment, allowing accurate assessment of drug distribution, diffusion rates, and convection effects that static models cannot capture
Solution Approach 2:
The patent systematically varies key parameters such as pH, temperature, protein concentration, and ionic composition to match the physiological range found in the vitreous humor. By adjusting these parameters to reflect actual in vivo conditions, the model achieves high measurement precision for drug behavior evaluation while maintaining reasonable experimental complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides an improved in vitro model that realistically simulates the eye's dynamic and metabolic barriers, enabling accurate analysis of substance behavior and stability, thereby enhancing the evaluation of drug formulations for therapeutic efficacy.
Implementation Method 1
The interaction between collagen and the proteoglycans creates a gel-like, rigid structure. As a result of this composition, small molecule drugs usually diffuse more easily than large molecules into this rigid matrix.
Implementation Method 2
a sample cell having a sample chamber which is delimited by a semi-permeable membrane
Implementation Method 3
guiding a flow of buffer fluid, in particular a continuous flow of a buffer fluid, over the outer surface of the semi-permeable membrane
Data Source
AI summary
The present invention relates to a method and an apparatus for simulating and analyzing the behavior of a substance in an eye, in particular in the vitreous humor. Further, the present invention refers to a method of providing a vitreous humor, and to a buffer fluid for use in such a method and apparatus.